CRIS Current Research Information System

LAURIOLA, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.047
EU - Europa 2.696
AS - Asia 1.065
AF - Africa 153
OC - Oceania 15
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.039
IT - Italia 1.074
GB - Regno Unito 449
CN - Cina 397
SG - Singapore 322
DE - Germania 290
SE - Svezia 288
IE - Irlanda 129
VN - Vietnam 120
IN - India 100
AT - Austria 81
FR - Francia 73
RU - Federazione Russa 57
TG - Togo 56
UA - Ucraina 50
ZA - Sudafrica 46
CI - Costa d'Avorio 41
BG - Bulgaria 40
JO - Giordania 40
EE - Estonia 39
CH - Svizzera 32
ID - Indonesia 25
FI - Finlandia 23
NL - Olanda 21
AU - Australia 15
IR - Iran 14
HK - Hong Kong 13
GR - Grecia 11
IL - Israele 11
BR - Brasile 9
ES - Italia 8
CA - Canada 7
CZ - Repubblica Ceca 7
DK - Danimarca 6
JP - Giappone 6
NG - Nigeria 5
RO - Romania 5
KR - Corea 4
HR - Croazia 3
PL - Polonia 3
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BE - Belgio 2
KE - Kenya 2
NO - Norvegia 2
PK - Pakistan 2
SC - Seychelles 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CU - Cuba 1
HU - Ungheria 1
JE - Jersey 1
LB - Libano 1
MA - Marocco 1
MN - Mongolia 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 6.989
Salva come PNG Salva come JPEG
Città #
Bologna 455
Southend 415
Chandler 354
Fairfield 324
Singapore 287
Houston 231
Ashburn 219
Seattle 172
Woodbridge 162
Wilmington 135
Dublin 126
Santa Clara 125
Cambridge 121
Princeton 117
Boardman 98
Dong Ket 79
Vienna 79
Ann Arbor 74
Redmond 61
Bremen 58
Lomé 56
Milan 56
Nanjing 50
Westminster 46
Berlin 43
Abidjan 41
Amman 40
Sofia 40
Padova 33
Rome 30
Beijing 28
New York 27
Bern 25
Jakarta 25
Saint Petersburg 25
Shanghai 25
Jinan 23
Los Angeles 23
Turin 21
Florence 20
Medford 20
Naples 20
Shenyang 19
San Diego 18
Jacksonville 16
Boydton 15
Helsinki 15
Jiaxing 15
Forlì 13
Guangzhou 13
Munich 13
Olalla 13
Reggio Emilia 13
Falls Church 11
Changsha 10
Dearborn 10
Haikou 10
London 10
Redwood City 10
Rehovot 10
Casalecchio Di Reno 9
Modena 9
Nanchang 9
San Francisco 9
Tianjin 9
Crevalcore 8
Ferrara 8
Lappeenranta 8
Norwalk 8
Visciano 8
Wuhan 8
Zhengzhou 8
Adelaide 7
Amsterdam 7
Cogollo del Cengio 7
Hebei 7
Marcon 7
Mülheim 7
Tehran 7
Bari 6
Brescia 6
Des Moines 6
Hong Kong 6
Paris 6
Pelhrimov 6
Portici 6
São Paulo 6
Aprilia 5
Bronshoj 5
Foggia 5
Fuzhou 5
Hangzhou 5
New Delhi 5
Potenza 5
Shenzhen 5
Taiyuan 5
Tokyo 5
Toronto 5
Carpi 4
Castel Maggiore 4
Totale 4.904
Salva come PNG Salva come JPEG
Nome #
EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer 188
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer 184
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects 178
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration 177
Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate 154
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 153
A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. 151
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 147
Submicroscopic alterations and gene expression profiles of human colon cancer cell lines in response to cetuximab, gefitinib and EGF 141
null 136
Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood 135
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection 134
null 128
The EGFR R521K polymorphism influences the risk to develop colorectal cancer. 127
Modulation of ERBB signaling from tissue homeostasis to cancer progression 126
Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. 125
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. 124
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 123
null 121
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 120
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 118
null 117
Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant. 115
Resistance to EGFR Targeting Treatments in Colorectal Cancer 113
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 112
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 111
The roadmap of colorectal cancer screening 111
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 110
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors 109
Estrogen Receptors and Melanoma: A Review 106
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor 104
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 103
qCMA: A Desktop Application for Quantitative Collective Cell Migration Analysis 102
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 102
A putative role for interleukin 1 pathway in resistance to EGFR blockade 101
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 98
The R521K polymorphism of EGFR influences the risk of colorectal cancer 94
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 93
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 93
null 87
Fibroblast-associated protein-α expression and BPV nucleic acid distribution in equine sarcoids 87
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 86
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions 84
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 84
Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals 83
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 82
null 82
null 81
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection 80
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling 78
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 78
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 77
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 76
null 74
null 72
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 71
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade 69
A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib 69
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 68
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 65
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 59
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 57
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 56
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation 55
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study 55
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer 52
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 48
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. 42
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 40
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result 37
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 37
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 34
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 29
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 28
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 24
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 23
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer 23
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 18
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 15
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression 14
Towards the emerging crosstalk: ERBB family and steroid hormones 7
Totale 7.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.044 0 0 0 0 129 178 174 177 190 69 62 65
2020/2021800 121 91 51 14 23 47 24 60 60 37 61 211
2021/20221.144 71 38 60 57 88 64 32 81 74 81 250 248
2022/20231.788 142 220 101 253 147 135 79 130 306 49 105 121
2023/2024752 59 93 40 75 60 144 40 46 25 75 41 54
2024/2025983 104 235 225 181 238 0 0 0 0 0 0 0
Totale 7.270